Contreras-Rodríguez A, Gómez-Díaz RA, Tanus-Hajj J, Talavera JO, Mondragón-González R, Wacher NH

Idioma: Ingles.
Referencias bibliográficas: 38
Paginas: 240-249
Archivo PDF: 205.29 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a “Coronary Heart Disease Equivalent”. An 18- year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28:2901-7.

2. Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Pública Mex. 2010;52(Suppl 1):S72-9.

3. Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. [Diabetes mellitus in Mexico. Status of the epidemic]. Salud Publica Mex. 2013;55(Suppl 2):S129-36.

4. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: Insulin resistance, beta-cell failure or both? Diabetes Care. 2005;28:638-44.

5. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: The relation of obesity and age of onset. Diabetes Care. 2001;24:1522-7.

6. Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr. 2004;144:656-9.

7. Becker A, Bos G, de Vegt F, et al. Cardiovascular events in type 2 diabetes: Comparison with nondiabetic individuals without and with prior cardiovascular disease. Eur Heart J. 2003; 24:1406-13.

8. Rifai N, Ballantyne CH, Cushman M, Levy D, Myers GL. Point: Highsensitivity C-reactive protein and cardiac C-reactive protein assays: Is there a need to differentiate? Clin Chem. 2006;52:1254-6.

9. Sabatine MS, Morrow DA, Jablonski KA, et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528-36.

10. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.

11. Kablack-Ziembicka A, Przewlocki T, Tracz W, et al. Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis. Atherosclerosis. 2007;193:395-400.

12. Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: Gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340-6.

13. Bots M, Hoes A, Koudstaal P, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. (The Rotterdam Study). Circulation. 1997;96:1432-7.

14. Yamasaki Y, Kodama M, Nishizawa H, et al. Carotid intimamedia thickness in Japanese type 2 diabetic subjects: Predictors of progression and relationship with incident coronary heart disease. Diabetes Care. 2000;23:1310-5.

15. Freedman DS, Srinivasan SR, Cresanta JL, Webber LS, Berenson GS. Cardiovascular risk factors from birth to 7 years of age: The Bogalusa Heart Study. Serum lipids and lipoproteins. Pediatrics. 1987;80:789-96.

16. Cantú B, Rodríguez S, Reynoso M, Marmolejo-Henderson R, Barinagarrementeria- Aldatz F. [Cardiovascular risk factors and carotid atherosclerosis detected by ultrasonography]. Salud Publica Mex. 1999;41:452-9.

17. Bashir R, Cooper CJ. Evaluation and medical treatment of peripheral arterial disease. Curr Opin Cardiol. 2003;18:436-43.

18. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.

19. Contreras EJ, Rodríguez-Moctezuma JR, López-Carmona JM, Munguía- Miranda C, Aranda-Moreno C, Peralta-Pedrero ML. [Differences of risk factors for peripheral arterial disease in type 2 diabetes patients in urban and suburban populations]. Rev Med Inst Mex Seguro Soc 2007; 45:117-22.

20. Manzano L, García-Díaz DJ, Gómez-Cerezo J, et al. [Clinical value of the ankle-brachial index in patients at risk of cardiovascular disease but without known atherothrombotic disease: VITAMIN study]. Rev Esp Cardiol. 2006;59:662-70.

21. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books, 1998.

22. Stein JH, Korcarz CE, Hurst RT, et al. The American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima- Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93-111.

23. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014;23:3-16.

24. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.

25. Hillier T, Pedula K. Complications in young adults with earlyonset type 2 diabetes. Diabetes Care. 2003;26:2999-3005.

26. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-34.

27. Tousoulis D, Papageorgiou N, Androulakis E, et al. Diabetes mellitus- associated vascular impairment: Novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol. 2013;62:667-76.

28. Smith SC, Allen J, Blair SN, et al. National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006;47:2130-9.

29. Yuk HB, Park HW, Jung IJ, et al. Analysis of carotid ultrasound findings on cardiovascular events in patients with coronary artery disease during seven-year follow-up. Korean Circ J. 2015;45:28-37.

30. Eikendal AL, Groenewegen KA, Anderson TJ, et al. Common carotid intima-media thickness relates to cardiovascular events in adults aged <45 years. Hypertension. 2015;65:707-13.

31. O’Leary DH, Polak JF, Wolfson Jr SK, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke. 1991;22:1155-63.

32. O’Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996;27:224-31.

33. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-9.

34. Lee EJ, Kim HJ, Bae JM, et al. Relevance of common carotid intima- media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol. 2007;28:916-9.

35. Lakka TA, Salonen R, Kaplan GA, Salonen JT. Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension. 1999;34:51-6.

36. Olsen MH, Fossum E, Hjerkinn E, et al. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia. J Hypertens. 2000;18:75-81.

37. O’Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: Results from the Cardiovascular Health Study. Circulation. 2006;113:388-93.

38. 38: DeVallance E, Fournier SB, Donley DA, et al. Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors? Int J Obes. 2015;39:244-53.